PARP1 inhibitors: contemporary attempts at their use in anticancer therapy and future perspective

Journal Title: Advances in Hygiene and Experimental Medicine - Year 2016, Vol 70, Issue

Abstract

Current cancer therapies are based mainly on the use of compounds that cause DNA damage. Unfortunately, even the combination therapies do not give rewarding effects, due to the high efficiency of DNA damage repair mechanisms in tumor cells. Therefore, the present studies should be focused on proteins that are involved in DNA repair systems. Poly(ADP-ribose) polymerase-1 is an example of a protein commonly known as an enzyme that plays a role in the detection of DNA damage and repair. Activation of PARP1 in response to DNA damage leads to poly-ADP-ribosylation of proteins contributing to DNA repair systems, therefore facilitating the maintenance of genome stability. On the other hand, inhibition of PARP1 enzyme results in the accumulation of DNA damage, which in turn contributes to cell death. Studies on inhibitors of PARP1 are still ongoing, and some of them are currently in the third phase of clinical trials. To date, only one representative of the PARP1 inhibitors, called olaparib, has been approved for anti-cancer therapy in the EU and the USA. Moreover, a growing body of evidence indicates a role of this protein in various intracellular processes such as bioenergetics, proliferation, regulation of gene expression, cell death as well as immunoregulation. A number of different intracellular processes regulated by PARP1 give rise to potential wider use of PARP1 inhibitors in treatment of other diseases, including immune or autoimmune disorders.

Authors and Affiliations

Ewelina Wiśnik, Marcin Ryksa, Maria Koter-Michalak

Keywords

Related Articles

Cathepsins: innate immune proteases that regulate viral entry into host cells

Cathepsins are group of endolysosomal proteases that regulate the mechanisms of innate and adaptive immunity, including cell adhesion and migration, antigen processing and presentation and resistance to several viral inf...

Accuracy of rapid influenza diagnostic test and immunofluorescence assay compared to real time RT-PCR in children with influenza A(H1N1)pdm09 infection

Introduction: The influenza burden among children is underestimated. The aim of our study was to estimate the accuracy of the rapid influenza detection test (RIDT) BD Directigen™ EZ Flu A+B® and direct immunofluorescenc...

Oddziaływania niekowalencyjne kation-π – ich rola w przyrodzie

Oddziaływania niekowalencyjne odgrywają niezwykle istotną rolę w organizmach żywych. Głównymi oddziaływaniami niekowalencyjnymi występującymi w przyrodzie są: oddziaływania jon-jon, oddziaływania dipol-dipol, wiązania wo...

Znaczenie badania mikrobiologicznego w diagnostyce zapalenia przyzębia – badanie kliniczne

Oral bacteria take the the form of biofilms, which – due to their complex structure – are characterized by high resistance to many external factors. The aim of the study was to analyze the composition of subgingival biof...

Rola zapalenia w patogenezie raka jelita grubego

Wyniki najnowszych badań, w co raz większym stopniu wiążą rozwój nowotworu z przewlekłym zapaleniem. Proces zapalny tworzy mikrośrodowisko sprzyjające rozwojowi nowotworów, w efekcie wiele z nich rozwija się w miejscach,...

Download PDF file
  • EP ID EP220760
  • DOI -
  • Views 123
  • Downloads 0

How To Cite

Ewelina Wiśnik, Marcin Ryksa, Maria Koter-Michalak (2016). PARP1 inhibitors: contemporary attempts at their use in anticancer therapy and future perspective. Advances in Hygiene and Experimental Medicine, 70(), 280-294. https://europub.co.uk/articles/-A-220760